SOTAC PHARMACEUTICALS
Back to Balance Sheet
|
SOTAC PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹1.54 Cr | ₹0.46 Cr | - | ₹0.40 Cr | - |
What is the latest Contingent Liabilities ratio of SOTAC PHARMACEUTICALS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹1.54 Cr |
| Mar2024 | ₹0.46 Cr |
| Mar2023 | - |
| Mar2022 | ₹0.40 Cr |
| Mar2021 | - |
How is Contingent Liabilities of SOTAC PHARMACEUTICALS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1.54 Cr | 230.82 | |
| Mar2024 | ₹0.46 Cr | 0 | |
| Mar2023 | - | -100.00 | |
| Mar2022 | ₹0.40 Cr | 0 | |
| Mar2021 | - | - | |
Compare Contingent Liabilities of peers of SOTAC PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SOTAC PHARMACEUTICALS | ₹111.0 Cr | -14.5% | -23% | -26.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹386,773.0 Cr | -6.8% | -7.6% | -4.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹159,540.0 Cr | -6.6% | -5.8% | 4.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,529.0 Cr | 0.9% | 5.7% | 27.3% | Stock Analytics | |
| CIPLA | ₹111,299.0 Cr | -4.8% | -8.1% | -3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,393.0 Cr | -2% | -8.8% | -12.9% | Stock Analytics | |
SOTAC PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SOTAC PHARMACEUTICALS | -14.5% |
-23% |
-26.1% |
| SENSEX | -2% |
-2.8% |
7.4% |
You may also like the below Video Courses